Cargando…
Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®)
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283794/ https://www.ncbi.nlm.nih.gov/pubmed/30415358 http://dx.doi.org/10.1007/s40120-018-0116-x |
_version_ | 1783379218636210176 |
---|---|
author | Annovazzi, Pietro Bertolotto, Antonio Brescia Morra, Vincenzo Gasperini, Claudio Montanari, Enrico Navarra, Pierluigi Patti, Francesco Pia Sormani, Maria Ghezzi, Angelo |
author_facet | Annovazzi, Pietro Bertolotto, Antonio Brescia Morra, Vincenzo Gasperini, Claudio Montanari, Enrico Navarra, Pierluigi Patti, Francesco Pia Sormani, Maria Ghezzi, Angelo |
author_sort | Annovazzi, Pietro |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-6283794 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | Springer Healthcare |
record_format | MEDLINE/PubMed |
spelling | pubmed-62837942018-12-26 Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®) Annovazzi, Pietro Bertolotto, Antonio Brescia Morra, Vincenzo Gasperini, Claudio Montanari, Enrico Navarra, Pierluigi Patti, Francesco Pia Sormani, Maria Ghezzi, Angelo Neurol Ther Letter Springer Healthcare 2018-11-10 /pmc/articles/PMC6283794/ /pubmed/30415358 http://dx.doi.org/10.1007/s40120-018-0116-x Text en © The Author(s) 2018 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) ), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Letter Annovazzi, Pietro Bertolotto, Antonio Brescia Morra, Vincenzo Gasperini, Claudio Montanari, Enrico Navarra, Pierluigi Patti, Francesco Pia Sormani, Maria Ghezzi, Angelo Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®) |
title | Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®) |
title_full | Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®) |
title_fullStr | Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®) |
title_full_unstemmed | Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®) |
title_short | Authors’ Response to the Letter to the Editor Regarding: A Comprehensive Review on Copemyl(®) |
title_sort | authors’ response to the letter to the editor regarding: a comprehensive review on copemyl(®) |
topic | Letter |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6283794/ https://www.ncbi.nlm.nih.gov/pubmed/30415358 http://dx.doi.org/10.1007/s40120-018-0116-x |
work_keys_str_mv | AT annovazzipietro authorsresponsetothelettertotheeditorregardingacomprehensivereviewoncopemyl AT bertolottoantonio authorsresponsetothelettertotheeditorregardingacomprehensivereviewoncopemyl AT bresciamorravincenzo authorsresponsetothelettertotheeditorregardingacomprehensivereviewoncopemyl AT gasperiniclaudio authorsresponsetothelettertotheeditorregardingacomprehensivereviewoncopemyl AT montanarienrico authorsresponsetothelettertotheeditorregardingacomprehensivereviewoncopemyl AT navarrapierluigi authorsresponsetothelettertotheeditorregardingacomprehensivereviewoncopemyl AT pattifrancesco authorsresponsetothelettertotheeditorregardingacomprehensivereviewoncopemyl AT piasormanimaria authorsresponsetothelettertotheeditorregardingacomprehensivereviewoncopemyl AT ghezziangelo authorsresponsetothelettertotheeditorregardingacomprehensivereviewoncopemyl |